| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $316K | +33.3% |
| Cost of Revenue | $789K | +58.4% |
| R&D Expense | $9.0M | +80.0% |
| SG&A Expense | $7.3M | +181.5% |
| Operating Income | -$18.4M | -275.8% |
| Net Income | -$29.9M | -255.5% |
| EPS (Basic) | -$2.38 | -51.6% |
| EPS (Diluted) | -$2.38 | -51.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.2M | +3813.8% |
| Accounts Receivable | $70K | +70.7% |
| Inventory | $1.4M | +8.4% |
| Current Assets | $6.8M | +2996.3% |
| Total Assets | $7.6M | -98.2% |
| Current Liabilities | $6.6M | -9.2% |
| Total Liabilities | $9.4M | -50.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.7M | -564.3% |
| Capital Expenditures | $153K | -29.8% |
| Investing Cash Flow | -$153K | -113.7% |
| Financing Cash Flow | $21.8M | +1356.3% |
| Free Cash Flow | -$17.8M | -519.2% |
| Stockholders' Equity |
| -$1.8M |
| +90.2% |